Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Oppenheimer Asset Management Inc. Has $38.39 Million Stock Position in Zoetis Inc. $ZTS
05:05am, Monday, 09'th Feb 2026
Oppenheimer Asset Management Inc. reduced its position in shares of Zoetis Inc. (NYSE: ZTS) by 6.1% in the third quarter, according to the company in its most recent filing with the Securities and Exc
Envestnet Asset Management Inc. Sells 331,544 Shares of Zoetis Inc. $ZTS
04:47am, Friday, 06'th Feb 2026
Envestnet Asset Management Inc. reduced its position in Zoetis Inc. (NYSE: ZTS) by 15.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
Zoetis Declares Second Quarter 2026 Dividend
04:15pm, Thursday, 05'th Feb 2026
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the second quarter of 2026. The dividend will
Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?
11:01am, Thursday, 05'th Feb 2026
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Zoetis (ZTS) is a Strong Momentum Stock
10:51am, Thursday, 05'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zoetis (ZTS) to Release Quarterly Earnings on Thursday
02:02am, Thursday, 05'th Feb 2026
Zoetis (NYSE: ZTS - Get Free Report) is expected to issue its Q4 2025 results before the market opens on Thursday, February 12th. Analysts expect Zoetis to post earnings of $1.40 per share and revenue
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
07:15pm, Tuesday, 03'rd Feb 2026
In the most recent trading session, Zoetis (ZTS) closed at $122.41, indicating a -2.02% shift from the previous trading day.
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 03'rd Feb 2026
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
11:02am, Tuesday, 03'rd Feb 2026
Let us look at some drug/biotech stocks, ZTS, PCRX, APLS, ACAD and DNLI, which are poised to beat on fourth-quarter 2025 earnings.
Here's Why Zoetis (ZTS) is a Strong Growth Stock
10:46am, Tuesday, 03'rd Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zoetis (ZTS) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Friday, 30'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Artisan Global Opportunities Fund Q4 2025 Portfolio Update
09:39am, Thursday, 29'th Jan 2026
Among our top contributors in Q4 were Argenx, Lam Research and Insmed. Among our biggest detractors in Q4 were Oracle, Netflix and BAE Systems. During the quarter, we initiated new positions in RTX (R
Bank of New York Mellon Corp Decreases Stake in Zoetis Inc. $ZTS
04:28am, Thursday, 29'th Jan 2026
Bank of New York Mellon Corp decreased its holdings in Zoetis Inc. (NYSE: ZTS) by 24.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Tuesday, 27'th Jan 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cullen Frost Bankers Inc. Has $5.07 Million Stake in Zoetis Inc. $ZTS
05:06am, Monday, 26'th Jan 2026
Cullen Frost Bankers Inc. reduced its stake in Zoetis Inc. (NYSE: ZTS) by 21.0% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i
